Everything published about AOD-9604: mechanism, research areas, results, regimens, risks, comparisons — plus the dated Vietnam price and ordering rules.
| Format | Price (index Nov 2, 2026) | Delivery |
|---|---|---|
| 5 mg | from 1 650 000 ₫ | Da Nang ~30 min · Vietnam 1–2 days |
AOD-9604 is a modified peptide fragment derived from the C-terminal region of human growth hormone. It was developed to investigate fat metabolism separately from the full hormone's growth-promoting effects.
An experimental peptide with preclinical metabolic work and human obesity trials. It is not equivalent to full-length growth hormone or to an approved weight-loss medicine.
A GH-derived fragment with a focused fat-metabolism research rationale. Its mechanism and injectable community protocols remain an exploratory direction.
Animal studies suggested effects on fat metabolism, driving interest in this GH fragment. A larger oral obesity trial did not show a significant weight-loss benefit over placebo; the proposed injectable cycles come from community practice.
Fat-metabolism research protocol: 300 micrograms subcutaneously once daily. Timing: preferably in the morning on an empty stomach or before cardio. Cycle: 20–30 days, followed by 2–4 weeks off. This is a proposed injectable protocol; oral formulations have separate study schedules.
Injection-site reactions or peptide sensitivity are possible. The safety of repeated injectable use is less well characterised than the studied oral formulations.
AOD-9604 is a short fragment designed around a metabolic hypothesis. Full-length GH has a broader receptor-mediated endocrine action. Their doses, outcomes and safety evidence cannot be substituted for one another.
from 1 650 000 ₫ for 5 mg (index Nov 2, 2026); final total confirmed in writing before payment.
No: research material, not a prescription drug; no medical claims.